1-5 of 5
Stein-Erik Gullaksen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting Venetoclax Resistance in TP53 -Mutated Acute Myeloid Leukemia

Ida Vänttinen, Tanja Ruokoranta, Joseph J Saad, Sari Kytölä, Monica Hellesøy, Stein-Erik Gullaksen, Pia-Sofia Ettala, Marja Pyörälä, Johanna Rimpiläinen, Timo Siitonen, Krister Wennerberg, Bjorn T. Gjertsen, Caroline A. Heckman, Mika Kontro, Heikki Kuusanmäki
Journal: Blood
Blood (2023) 142 (Supplement 1): 2927.
https://doi.org/10.1182/blood-2023-189340
Published: 2023
Journal Articles

The Transmembrane Protein CD37 Is Not a Promising Therapeutic Target in Acute Myeloid Leukaemia

Tara Helen Dowling Dowling Steinsland, MSc, Stein-Erik Gullaksen, MS, PhD, Geir Bredholt, PhD, Calum Leitch, PhD, Mireia Mayoral Safont, BS, Øystein Bruserud, MD PhD, Mihaela Popa, Astri Maaland, Helen Heyerdahl, PhD, Jostein Dahle, PhD, Bjorn T. Gjertsen, MD PhD, Emmet Mccormack, BSc, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26.
https://doi.org/10.1182/blood-2020-142899
Published: 2020
Journal Articles

A 36-Dimensional Cytometry by Time of Flight (CyTOF) Analysis of De Novo Acute Myeloid Leukemia (AML) Patients Eligible for Intensive Chemotherapy

Benedicte Sjo Tislevoll, MD, Oda Helen Eck Fagerholt, Nello Blaser, MS, PhD, Monica Hellesøy, MS, PhD, Stein-Erik Gullaksen, MS, PhD, Pilar Ayuda Duran, MS, PhD, Laure Isabelle Piechaczyk, MS, Dagim Tadele, MS, Jørn Skavland, MS, PhD, Sonia Gavasso, MS, PhD, Jorrit Enserink, MS, PhD, Yngvar Fløisand, MD PhD, Bjorn Gjertsen, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1502.
https://doi.org/10.1182/blood-2018-99-116943
Published: 2018
Journal Articles

Single Cell Signaling Pharmacodynamics in a Phase 1b Trial of the Axl Inhibitor BGB324 in Acute Myeloid Leukemia

Monica Hellesøy, PhD, Stein-Erik Gullaksen, Benedicte Sjo Tislevoll, Oda Helen Eck Fagerholt, Hakon Reikvam, MD PhD, Sonja Loges, MD PhD, Jorge Cortes, MD, Michael Heuser, MD, Jörg Chromik, Jørn Skavland, PhD, André Sulen, Øystein Bruserud, MD PhD, Jim Lorens, PhD, Gro Gausdal, PhD, David Micklem, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3995.
https://doi.org/10.1182/blood.V128.22.3995.3995
Published: 2016
Journal Articles

Single-Cell Immune Signatures in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Treated with Nilotinib: An ENEST1st Sub Study

Stein-Erik Gullaksen, MSc, Jørn Skavland, PhD, Krzysztof Warzocha, MD PhD, Sonia Gavasso, PhD, Vinko Tosevski, PhD, Noortje Thielen, MDPhD, Jaroslava Voglova, MD, Augustin Ferrant, MD PhD, Werner Linkesch, MD, Josef Thaler, MD, Alois Lang, MD, Jesper Stentoft, Tobias Gedde-Dahl, MDPhD, Henrik Hjorth-Hansen, MD PhD, Waleed Majeed, MD, Gregor Verhoef, MD PhD, Andrzej Hellmann, MD PhD, Georgi G. Mihaylov, MD PhD, Claudia Dumrese, PhD, Frank Giles, MDMB, Andreas Hochhaus, MD, Sieghart Sopper, PhD, Leif Stenke, MD PhD, Boris Labar, MD PhD, Jeroen Janssen, MD, Kimmo Porkka, MD PhD, Gert J. Ossenkoppele, MD PhD, Satu Mustjoki, MD PhD, Dominik Wolf, MD, Bjorn T. Gjertsen, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4022.
https://doi.org/10.1182/blood.V126.23.4022.4022
Published: 2015